www.fdanews.com/articles/61636-epeius-biotechnologies-receives-accelerated-approval-for-rexin-g-in-the-philippines
EPEIUS BIOTECHNOLOGIES RECEIVES ACCELERATED APPROVAL FOR REXIN-G IN THE PHILIPPINES
August 11, 2006
Epeius Biotechnologies announced the Bureau of Food and Drugs (BFAD), the Philippine drug regulatory body, has granted Epeius Biotechnologies accelerated approval for the company's lead clinical product, Rexin-G for the treatment of all solid tumors. This approval closely follows the recent granting of an Expanded Access Program by BFAD to Epeius for Rexin-G, which extended Rexin-G clinical applications to patients with solid tumors, including but not limited to pancreatic cancer. Drug Newswire (http://www.drugnewswire.com/4685/)